Study on the Potential Mechanism of Semen Strychni against Myasthenia Gravis Based on Network Pharmacology and Molecular Docking with Experimental Verification

Figure 4

Molecular docking diagram of some active compounds and core targets. (a) Strychnine-MAPK14, (b) strychnine-CHRNA4, (c) vomicine-CHRNA4, (d) (s)-stylopine-CHRNA4, and (e) brucine-N-oxide-CHRNA4. Ligand docked in the binding pocket of protein was placed at the left, the interaction diagram was below, and 2D ligand interaction diagram was shown at the right.

(a)

(b)

(c)

(d)

(e)